Literature DB >> 7023762

A radioimmunoassay for serum and gingival crevicular fluid antibodies to a purified protein of Streptococcus mutans.

R Smith, T Lehner.   

Abstract

A solid-phase radioimmunoassay was developed to measure serum IgG antibodies to a purified protein antigen I/II prepared from Streptococcus mutans. The assay was specific to this antigen and significant binding of 125I-radiolabelled antiserum was found only in sera from rhesus monkeys immunized with the antigen I/II but not in sham-immunized monkeys or those immunized with streptococcal antigen III. A very significant correlation was found in serum IgG antibodies tested by the radioimmunoassay and an immunofluorescent technique (r = 0.88, P less than 0.001). The sensitivity of the double-layer radioimmunoassay was increased 10 times by the addition of a third antibody layer and this enabled gingival crevicular fluid antibodies to be measured. Comparison of paired samples of serum and crevicular fluid revealed a very significant correlation between IgG antibodies to streptococcal antigen I/II in the the two fluids (P less than 0.001). These findings suggest that serum antibodies can reach the tooth surface via gingival crevicular fluid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7023762      PMCID: PMC1537267     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Serum and salivary antibodies to cariogenic bacteria in man.

Authors:  S J Challacombe; T Lehner
Journal:  J Dent Res       Date:  1976-04       Impact factor: 6.116

3.  Immunization with dextransucrases and glycosidic hydrolases.

Authors:  J A Hayashi; I L Shklair; A N Bahn
Journal:  J Dent Res       Date:  1972 Mar-Apr       Impact factor: 6.116

4.  Antibodies to Streptococcus mutans and immunoglobulin levels in children with dental caries.

Authors:  T Lehner; J J Murray; G B Winter; J Caldwell
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

5.  Antibodies to an extract of Streptococcus mutans, containing glucosyltransferase activity, related to dental caries in man.

Authors:  S J Challacombe; B Guggenheim; T Lehner
Journal:  Arch Oral Biol       Date:  1973-06       Impact factor: 2.633

6.  Generation of specfic T-cell suppressor function induced by Streptococcus mutans in monkeys and mice.

Authors:  J R Lamb; S Kontiainen; T Lehner
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

7.  Serum glucosyltransferase-inhibiting antibodies and dental caries in rhesus monkeys immunized against Streptococcus mutans.

Authors:  M W Russell; S J Challacombe; T Lehner
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

8.  Effective immunity to dental caries: protection of gnotobiotic rats by local immunization with Streptococcus mutans.

Authors:  S M Michalek; J Webb; J M Navia; A F Rahman; D W Legler
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Purification and properties of a protein surface antigen of Streptococcus mutants.

Authors:  M W Russell
Journal:  Microbios       Date:  1979

10.  Specificity of antibodies induced by Streptococcus mutans during immunization against dental caries.

Authors:  M W Russell; S J Challacombe; T Lehner
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

View more
  19 in total

1.  Mapping major and minor T-cell epitopes in vitro and their immunogenic or tolerogenic effect in vivo in non-human primates.

Authors:  P R Walker; R Smerdon; J Haron; T Lehner
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

2.  T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II.

Authors:  C G Kelly; S Todryk; H L Kendal; G H Munro; T Lehner
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  Proteolysis of the 185,000 MW streptococcal cell wall antigen generating 4000 and 6000 MW peptides with distinct antigenic determinants.

Authors:  C G Mitchell; T Lehner
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

4.  An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans.

Authors:  J K Ma; M Hunjan; R Smith; C Kelly; T Lehner
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  The detection and specificity of class specific antibodies to whole bacterial cells using a solid phase radioimmunoassay.

Authors:  C Czerkinsky; A S Rees; L A Bergmeier; S J Challacombe
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

6.  Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries.

Authors:  T Lehner; J Caldwell; R Smith
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

7.  Lack of antibodies to human heart tissue in sera of rhesus monkeys immunized with Streptococcus mutans antigens and comparative study with rabbit antisera.

Authors:  L A Bergmeier; T Lehner
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Local oral immunization with synthetic peptides induces a dual mucosal IgG and salivary IgA antibody response and prevents colonization of Streptococcus mutans.

Authors:  T Lehner; J Haron; L A Bergmeier; A Mehlert; R Beard; M Dodd; B Mielnik; S Moore
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

9.  Separation and characterization of a 14,000-dalton cyanogen bromide-generated peptide from a 185,000-dalton streptococcal antigen.

Authors:  L A Bergmeier; T Lehner
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  Immune responses to Streptococcus sobrinus surface protein antigen A expressed by recombinant Salmonella typhimurium.

Authors:  T A Doggett; E K Jagusztyn-Krynicka; R Curtiss
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.